---
schema_version: "secwatch.filing_event.v1"
accession: "0001753926-26-000315"
form_type: "8-K"
ticker: "SRTS"
cik: "0001494891"
company_name: "Sensus Healthcare, Inc."
filed_at: "2026-02-12T23:59:59+00:00"
generated_at: "2026-05-16T02:59:38.314851+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Sensus Healthcare Q4 2025 revenue $4.9M, net loss $3.2M; CMS code boost effective Jan 2026

## Summary
- Q4 revenue $4.9M, down from $13.1M YoY; net loss $3.2M ($0.19/sh) vs net income $1.5M ($0.09/sh) in Q4 2024.
- Shipped 14 SRT systems in Q4 (8 US, 6 international), up from 6 in Q3 excluding largest customer.
- Ended 2025 with $22.1M cash and no debt; full-year revenue $27.5M, net loss $7.7M.
- CMS published dedicated CPT codes for SRT effective Jan 1, 2026, providing 300% per-fraction increase and reimbursement certainty.
- Expects sequential revenue growth in Q1 2026 and full-year profitability; FDA program delivered 11,411 treatments (+8x YoY).

## SEC filing metadata
- accession: 0001753926-26-000315
- form_type: 8-K
- ticker: SRTS
- cik: 0001494891
- company_name: Sensus Healthcare, Inc.
- filed_at: 2026-02-12T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1494891/000175392626000315/0001753926-26-000315-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1494891/000175392626000315/g085130_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001753926-26-000315
- JSON: https://secwatch.observer/filing/0001753926-26-000315.json
- Plain text: https://secwatch.observer/filing/0001753926-26-000315.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.